N/A N=13 Effects of Clobazam on Sleep and Daytime Function in Patients With Epilepsy
Epilepsy
Primary: Change in Sleep (Total Sleep Time) in Patients With Epilepsy Treated With Clobazam — 493.2; 457.9 minutes
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=2,572 A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients
Heart Failure With Preserved Ejection Fraction
Primary: Change From Baseline in N-terminal Pro-brain Natriuretic Peptide (NT-proBNP) at Week 12 — 0.8218; 0.9828 Ratio — p=<0.0001
Phase 4 N=69 Cetylpyridium Chloride (CPC) Based Chewing Gum and Gingivitis
Gingivitis · Plaque, Dental · Periodontal Diseases
Primary: Degree of Plaque as Assessed by the Turesky Modification of the Quigley-Hein Plaque Index — 0.41; 0.43 score on a scale
Phase 2 N=421 A Study to Assess Safety, Tolerability, and Immunogenicity of Three Heterologus 2-dose Regimens of the Candidate Prophylactic Vaccines for Ebola in Healthy Adults
Ebola Viral Disease
Primary: Number of Participants With Unsolicited Adverse Events (Groups 1, 2 and 3) — 4; 6; 6; 62 Participants
N/A N=12 A Self-Management Program for Completers of Trauma-Focused Therapy for PTSD
Posttraumatic Stress Disorder
Primary: Credibility-Expectancy Scale (Credibility Subscale) — 6.39 score on a scale
Phase 2 N=46 Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO
Macular Edema · Retinal Vein Occlusion
Primary: Total Number of Times a Subject Qualifies to be Administered IVT Aflibercept in Each Arm — 18; 7; 3; 12 Participants
N/A N=278 Surgical Approach for Pilonidal Disease
Pilonidal Disease
Primary: Mobilization Time,Days — 3.21; 12.3 days
Phase 4 N=102 Propofol for Pediatric Tracheal Intubation With Deep Anesthesia During Sevoflurane Induction
Anesthesia Intubation Complication
Primary: Estimated Propofol Doses Producing 50% Excellent Intubation Conditions — 1.48; 0.00; 0.07; 2.35 mg/kg
Phase 2 N=41 Catheter Related - Gram Positive Bloodstream Infections
Bloodstream Infection
Primary: Clinical Response Within 48 Hours — 28 Participants
Phase 3 N=19 Staging Prostate Cancer With Hybrid C11-Choline PET/MR and mpMRI
Prostate Adenocarcinoma
Primary: Uptake Value of C11-choline — 6.2 Ratio
N/A N=11 Epidural Lavage Study for Lumbar Stenosis
Lumbar Spinal Stenosis
Primary: Visual Analogue Scale — 6.2; 5.0; 5.0; 0.8 score on a scale
Phase 2 N=8 Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease
Crohn's Disease
Primary: Change in Disease Activity by Harvey Bradshaw Index — -5; -3 score on a scale
N/A N=963 XIENCE 28 Global Study
Bleeding Disorder · Stroke, Ischemic · Stroke Hemorrhagic
Primary: Number of Participants With Composite of Net Adverse Clinical Endpoint (NACE), by Propensity Score Quintiles — 2; 5; 10; 15 Participants
N/A N=943 Multiple Myeloma (MM) Profile in Brazil: A Retrospective Observational Analysis
Multiple Myeloma
Primary: Number of Multiple Myeloma (MM) Participants Categorized by Clinical Characteristics — 342; 366; 48; 36 Participants
Phase 3 N=30 Study of the Drug Efalizumab (Raptiva), for Adult Patients With Moderate to Severe Plaque Psoriasis
Psoriasis
Primary: Number of Participants With Clinical Improvement of Target Lesions — 18 Participants